AU Patent

AU2006310283A1 — Crystalline salts of 7-[4-(4-naphthalen-1-yl-piperazin-1-yl)-but oxy]-3,4-dihydro-1H-(1,8)naphthyridin-2-one

Assigned to Pfizer Products Inc · Expires 2007-05-10 · 19y expired

What this patent protects

Patent listed against Aristada.

Drugs covered by this patent

Patent Metadata

Patent number
AU2006310283A1
Jurisdiction
AU
Classification
—
Expires
2007-05-10
Drug substance claim
No
Drug product claim
No
Assignee
Pfizer Products Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.